bakuchiol
Botanicalexperimental
Bakuchiol is a meroterpenoid in the class terpenophenol. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 24, 2017 (NCT03112863)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Loading structure…
SMILES
C=C[C@@](C)(/C=C/c1ccc(O)cc1)CCC=C(C)C- Mol. weight
- 256.39 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaBakuchiol ↗
- ChEMBLCHEMBL262344 ↗
Also known as
- bakuchiol
- bakuchiol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05069272 | N/A | Sep 10, 2021 | Princeton Consumer Research Inc., Sytheon Ltd. |
| NCT03112863 | Phase 1/Phase 2 (Phase 2) | Mar 24, 2017 | University of California, Davis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Princeton Consumer Research Inc. | For profit | 1 | 0 | 1 | 2021 |
| Sytheon Ltd. | For profit | 1 | 1 | 1 | 2021 |
| University of California, Davis | Academic/Hospital | 1 | 1 | 1 | 2017 |
3 organizations
Page 1 / 1